Applications published 3 March 2007

Synthesis of metabolically stable analgesics, pain medications and other agents
Human Biomolecular Research Institute 1758452*

C-purine nucleoside analogues as inhibitors of RNA-dependent RNA viral polymerase
Merck; Isis Pharmaceuticals 1758453*

Compsn containing opioid antagonists
Adolor 1758458*

A new adjuvant compsn
Cognis IP Management 1758459*

Swellable dosage form comprising gellan gum
Egalet A/S 1758557*

Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1
Baxter International; Baxter Healthcare; Children's Hospital of Pittsburgh 1758558*

Process for the selective increase of release of an active material from a pharmaceutical compsn
Pfizer Products 1758559*

Hormonal contraceptive containing a combination of ethinyl estradiol and chlormadinone acetate
Gruenenthal 1758560*

Protective microcontainers
MPG Max-Planck-Gesellschaft zur Foerderung der Wissenschaften 1758561*

Compsn and methods for bone formation and remodelling
Enzo Therapeutics; Zhang, Yazhou; Liu, Peng; Li, Xiaofeng; Zhang, Jie; Shan, Jufang; Engelhardt, Dean 1758562*

Combination therapy with glatiramer acetate and minocycline for the treatment of multiple sclerosis
Teva Pharmaceutical 1758563*

Synergistic methods and compsns for treating cancer
Bristol-Myers Squibb 1758564*

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
Arena Pharmaceuticals 1758565*

Use of CB2 receptors antagonists for the treatment of Huntington's disease
Pharmos 1758566*

Partially-fluorinated ethers, compsns and uses thereof, for long-term tamponade in the eye
The Trustees of Columbia University in the City of New York; Simpson, Roderic Nigel Fraser 1758567*

System and method for transdermal delivery of an anticoagulant
Alza 1758568*

Guanylhydrazone salts, compsns, processes of making and methods of using
Cytokine Pharmasciences 1758569*

Compsn for treatment of a hydrofluoric acid burn
Cameco 1758570*

CRTH2 receptor ligands for therapeutic use
7TM Pharma A/S 1758571*

Combinations of hyaluronic acid and polyunsaturated fatty acids
Bionovate 1758572*

A pharmaceutical compsn and its use
Tillotts Pharma 1758573*

Pharmaceutical compsns containing polyunsaturated fatty acid and at least one of an immunosuppressive agent or an antineoplastic agent
Tillotts Pharma 1758574*

Counteracting drug-induced obesity using GLP-1 agonists
Novo Nordisk 1758575*

Topical and intravaginal microbicidal and antiparasitic compsns comprising quassinoids or quassinoid-containing plant extracts
Diehl, Christian; Chami de Diehl, Silvia 1758576*

Novel compounds, pharmaceutical compsns containing same, and methods of use for same
Fasgen. LLC; The Johns Hopkins University 1758577*

Novel indazole carboxamides and their use
SmithKline Beecham 1758578*

CRTH2 receptor ligands for medicinal use
7TM Pharma 1758579*

N-substituted piperidines and their use as pharmaceuticals
Incyte 1758580*

Combinations comprising a 4-iso-quinoline derivative and anti-HIV agents
Japan Tobacco 1758581*

Amido compounds and their use as pharmaceuticals
Incyte 1758582*

Arylpiperazine derivatives useful as adrenergic receptor antagonists
Ranbaxy Laboratories 1758583*

Methods for treating a mammal before, during and after cardiac arrest
Abbott Laboratories 1758584*

HIV integrase inhibitors
Merck 1758585*

Compsn in spray form comprising a combination of a corticoid and a vitamin D derivative in an oily phase
Galderma 1758586*

Use of a pharmaceutical compsn comprising calcitriol and clobetasol propionate for the treatment of psoriasis
Galderma 1758587*

Pharmaceutical compsn comprising an ointment and two solubilised active principles
Galderma 1758588*

Compsn for the treatment of psoriasis comprising a silicone agent, a corticosteroid and vitamin D or a derivative thereof
Galderma 1758589*

Use of a detergent for the non-surgical removal of fat
Los Angeles Biomedical Research Institute at Harbour-UCLA Medical Centre 1758590*

Invert emulsion compsn containing calcitrol and clobetasol 17-propionate, and uses thereof in cosmetics and dermatology
Galderma 1758591*

Treatment of cancer in paediatric patients
Abbott Laboratories 1758592*

Vascular damaging agents for administration as an intravenous infusion
Angiogene Pharmaceuticals 1758593*

Combination for inhibiting bone resorprtion comprising a bisphosphonate (alendrona) and a vitamin D (cholecalciferol)
Merck 1758594*

Use of lipid conjugates in the treatment of diseases
Yissum Research Development Company of the Hebrew University of Jerusalem 1758595*

Purine derivatives as adenosine A1 receptor agonists and methods of use thereof
Inotek Pharmaceuticals 1758596*

Use of drug combinations for treating insulin resistance
Diamedica 1758597*

Irritation-reducing ocular ionthophoretic device
Eyegate Pharma 1758598*

Orally-administrable compsns comprising stable amorphous calcium carbonate
Ben Gurion University of the Negev Research and Development Authority 1758599*

Methods and compsns for treating mood disorder
Mood Management Sciences 1758600*

Treatment with cisplatin and an EGFR-inhibitor
F Hoffmann-La Roche 1758601*

Pharmaceutical active substance extracted from Lycosa tarantula
Toximed 1758602*

Treatment for asthma and arthritis and other inflammatory diseases
Bionovate 1758603*

Method for improved breast milk feeding to reduce the risk of allergy
Biogaia 1758604*

Prouroguanylin as therapeutic and diagnostic agents
The University of North Carolina at Chapel Hill 1758605*

Novel use of peptide compounds for treating essential tremor and other tremor syndromes
Schwarz Pharma 1758606*

Medicament comprising PTX3, alone or in combination with TSG-6, for treating degenerative diseases of cartilage and bone and treating female infertility
Defiante Farmaceutica 1758607*

Conjugates of hydroxyethyl starch and erythropoietin
Fresenius Kabi Deutschland 1758608*

Vaccine against HPV16 and HPV18 and at least another HPV type selected from HPV31, 45 or 52
GlaxoSmithKline Biologicals 175609*

Methods of treating cancer using IL-21 and monoclonal antibody therapy
Zymogenetics 1758610*

Use of liver-selective glucokinase activators
Novo Nordisk 1758611*

Compsn comprising intercalated functional-active organic compounds
Eastman Kodak 1758612*

Compsns and methods for modulating bone mass
Baylor College of Medicine 1758613*

Method for expressing sialylated glycoproteins in mammalian cells and cells thereof
The National University of Singapore; The Massachusetts Institute of Technology 1758614*

Combination treatment of cancer with elicitor of gene product and gene-product targeting agent
Board of Regents, The University of Texas System; Introgen Therapeutics 1758615*

Use in the medical, diagnostic and phlebological field of a mixture of sterile and physiologically acceptable gases
Tessari, Lorenzo; Cavezzo Attilio; Cabrera Garrido, Antonio 1758616*

Stable liquid and lyophilised formulation of proteins
PDL BioPharma 1758617*